Archives dans la recherche sur le cancer

  • ISSN: 2254-6081
  • Indice h du journal: 13
  • Note de citation du journal: 3.58
  • Facteur d’impact du journal: 3.12
Indexé dans
  • Infrastructure nationale des connaissances en Chine (CNKI)
  • CiteFactor
  • OCLC - WorldCat
  • Publions
  • Fondation genevoise pour la formation et la recherche médicales
  • Google Scholar
  • Laboratoires secrets des moteurs de recherche
Partager cette page

Abstrait

A scoping study of patient-reported outcomes in sarcoma

Peter Mazzone

Sarcoma could be a heterogeneous cluster of tumours, typically poignant young patients and associated with each endogenous and exogenous risk factor. The importance of getting the patient's perspective of the unwellness expertise is imperative. Patient-reported outcomes (PROs) square measure the outcomes that return directly from the patient. They embrace symptoms, useful health, well-being, quality of life, psychological problems, among different indicators according by the patients. The target of this scoping review was to map the execs in malignant neoplastic disease patients and the way they're measured. Epigenetic mechanisms of tumorigenesis are concerned in mesenchymal tumors starting from chondroblastoma and large cell tumour of bone to sarcoma, malignant peripheral nerve sheath tumor, secretion malignant neoplastic disease, and epithelioid malignant neoplastic disease and Ewing malignant neoplastic disease - all diseases that gift in an exceedingly younger patient population than most cancers. Finally, we have a tendency to review current and potential future approaches for the event of malignant neoplastic disease therapies supported this rising understanding of body substance deregulation.